Company Search:
Advanced Search
Sponsored Links
Oriola KD Oyj Company Snapshot
Oriola KD Oyj operates within the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares Oriola KD Oyj with three other drug stores in Europe: Pelion SA of Poland (2015 sales of 8.46 billion Polish New Zlotys [US$2.15 billion] of which 69% was Wholesale Trade), Neuca SA of Poland (6.95 billion Polish New Zlotys [US$1.77 billion] of which 100% was Pharmaceutical Wholesale), and Farmacol SA which is also based in Poland (5.91 billion Polish New Zlotys [US$1.50 billion] of which 102% was Wholesale).

Sales Analysis. During the year ended December of 2015, sales at Oriola KD Oyj were 1.63 billion Euro (US$1.79 billion). This is a very small increase of 0.9% versus 2014, when the company's sales were 1.61 billion Euro. Despite this increase, sales are still well below the level achieved in 2013, when Oriola KD Oyj reported sales of 2.60 billion Euro. Sales of Pharmaceutical Trade Sweden saw an increase of 1.2% in 2015, from 1.18 billion Euro to 1.19 billion Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Oriola KD Oyj
  Stock Performance Chart for Oriola KD Oyj
  Stock Data: Recent Stock Performance:
  Current Price (10/14/2016): 4.12
(Figures in Euro)
1 Week -1.0%   13 Weeks 0.0%  
4 Weeks -3.3%   52 Weeks 2.2%  
Oriola KD Oyj Key Data:
  Ticker: OKDBV Country: Finland
  Exchanges: HEL Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2015 Sales 1,626,300,000
(Year Ending Jan 2016).
Employees: 2,353
  Currency: Euro Market Cap: 747,324,291
  Fiscal Yr Ends: December Shares Outstanding: 181,389,391
  Share Type: Osake B Closely Held Shares: 50,532,330
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.